• 제목/요약/키워드: Melkersson-Rosenthal Syndrome

검색결과 3건 처리시간 0.021초

Melkersson-Rosenthal 증후군 1례 (A Case of Melkersson-Rosenthal Syndrome)

  • 피대훈;나요원;장기영;서우근;이기형;은백린
    • Clinical and Experimental Pediatrics
    • /
    • 제45권10호
    • /
    • pp.1292-1298
    • /
    • 2002
  • 저자들은 반복적인 안면 신경 마비의 과거력을 가진 환아에서 좌측 안면부의 부종과 함께 나타난 Melkersson-Rosenthal 증후군 증례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

Melkersson-Rosenthal Syndrome -증례보고- (Melkersson-Rosenthal Syndrome -Report of a Case-)

  • 김태정;박욱;이성근;김일호;송후빈;황경호;김선종;김성열
    • The Korean Journal of Pain
    • /
    • 제2권1호
    • /
    • pp.57-60
    • /
    • 1989
  • The Melkersson-Rosenthal (M-R) syndrome consists of a triad of (1) recurrent peripheral facial nerve paralysis which develops alternately on both sides of face, (2) non-inflammatory facial edema, and (3) fissuring of tongue. A 59 years old female patient developed the left facial palsy on September, 1988. Right facial palsy developed continuously 2 months later after the spontaneous remission of left facial palsy. On February, 1989, we have found out M-R syndrome which accompanied with migraine type of intermittent headache, and hypertension in one attack of cerebral stroke several years ago, there were no diabetes mellitus, pulmonary tuberculosis and brain tumor in clinical studies. Although the causes of this syndrome were not noted, we performed the stellate ganglion block and transcutaneous electrical nerve stimulation for treatment of the palsy, but the clinical effectiveness of these were not satisfactory.

  • PDF

Photobiomodulation and Miescher's cheilitis granulomatosa: case report

  • Porrini, Massimo;Garagiola, Umberto;Rossi, Margherita;Bosotti, Moreno;Marino, Sonia;Gianni, Aldo Bruno;Runza, Letterio;Spadari, Francesco
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제42권
    • /
    • pp.35.1-35.6
    • /
    • 2020
  • Background: Miescher's cheilitis granulomatosa (MCG) is a rare chronic inflammatory disease and is known as the monosymptomatic clinical form of Melkersson-Rosenthal syndrome (MRS). It is characterised by swelling of one or both lips and more frequently affects the upper lip. Histopathological findings show the presence of numerous inflammatory infiltrates and granuloma formations. Pharmacological treatments and surgery have provided results that are positive yet insufficiently stable in the long term. The clinical case described is of a 68-year-old female patient with a diagnosis of MCG of the upper lip. Case presentation: The patient was diagnosed and treated at the Oral Medicine and Oral Pathology outpatient clinic of Maxillofacial and Odontostomatology Unit, Fondazione Cà Granda IRCCS Ospedale Maggiore Policlinico. The patient was recommended localised treatments of photobiomodulation (PBM) using a diode laser with a 635 nm and 980 nm dual-wavelength (λ) approach, a 600-micron fibre, and a handpiece with a 1-cm-diameter lens at 300 mW. Three treatments a week were administered for four weeks for a total of 12 treatment sessions (T1-T12). After that, the patient had a long follow-up period of about 2 years. The therapeutic results were clear from the initial stages of treatment. There was an immediate, gradual, and consistent reduction in labial swelling. A reduction in the size of the lip by about 35% at T10-T12 was observed, returning the size and volume of the upper lip within the normal clinical range. The painful symptoms subsided after the seventh treatment (T7). The histopathological check at 3 months and the follow-up in particular confirmed the disease was in remission with satisfactorily stable treatment results. Moreover, the patient did not use any other treatments on the area from the early laser treatments through to the end of the follow-up period. Conclusions: Our experience describes a clinical case of MCG treated with PBM and effectively resolved with a reduction of the lip swelling. The real success of the treatment emerged over time, showing that the tissue healing was stable. In absence of any collateral phenomena, this confirms the effective and documented therapeutic potential of PBM for chronic inflammatory infiltrates.